Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Landos Biopharma, Inc. (LABP)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 39,160,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Landos Biopharma is a clinical-stage biopharmaceutical company, focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target LANCL2, NLRX1 and PLXDC2, which are immunometabolic pathways. Through its LANCE platform, Co. has identified seven immunometabolic targets. Co.'s primary product candidate, omilancor is a gut-restricted oral therapeutic that is designed to engage the target lanthionine synthetase C-like protein 2 (LANCL2). NX-13 is a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor and LABP-104 is a systemically bioavailable, oral therapeutic that targets LANCL2.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 6,020,868
Total Sell Value $0 $0 $0 $207,000
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 37
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bassaganya-Riera Josep 10% Owner   –       –       •   2023-02-28 4 S $0.00 $0 I/I (5,720,868) 0     -
   Wong Roderick 10% Owner   –       –       •   2022-09-23 4 S $0.69 $207,000 I/I (300,000) 3,975,722     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2022-08-05 4 GA $0.00 $0 I/I 500,000 500,000     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2022-08-05 4 GD $0.00 $0 I/I 500,000 3,494,208     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-20 4 S $4.75 $157,804 I/I (33,194) 4,994,208     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-17 4 S $4.84 $174,096 I/I (36,000) 5,027,402     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-16 4 S $5.11 $124,251 I/I (24,301) 5,063,402     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-16 4 GD $0.00 $0 I/I 58,651 5,087,703     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-15 4 S $5.02 $216,032 I/I (43,000) 5,146,354     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-14 4 S $5.10 $214,284 I/I (42,000) 5,189,354     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-13 4 S $5.37 $214,840 I/I (40,000) 5,231,354     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-10 4 S $5.77 $230,800 I/I (40,000) 5,271,354     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-09 4 S $6.26 $69,829 I/I (11,162) 5,311,354     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-08 4 S $6.65 $169,723 I/I (25,530) 5,322,516     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-07 4 S $6.58 $276,528 I/I (42,000) 5,348,046     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-06 4 S $6.17 $221,976 I/I (36,000) 5,390,046     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-03 4 GD $0.00 $0 I/I 1,869,008 5,426,046     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-03 4 S $6.15 $221,364 I/I (36,000) 7,295,054     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-02 4 S $6.45 $192,633 I/I (29,861) 7,331,054     -
   Bassaganya-Riera Josep 10% Owner   –       –       •   2021-12-01 4 S $7.01 $226,110 I/I (32,237) 7,360,915     -
   Chauhan Jyoti ED, Global Clinical Operations   •       –      –    2021-07-26 4 OE $1.86 $219,580 D/D 118,054 209,299     -
   Edelman Joseph Director   –       •       •   2021-02-09 4 B $13.80 $1,403,559 I/I 99,681 7,299,751 2.25     -
   Poukalov Konstantin Director   –       •       •   2021-02-09 4 B $13.80 $1,403,559 I/I 99,681 14,869,915 2.25     -
   Edelman Joseph Director   –       •       •   2021-02-08 4 B $11.38 $1,503,061 I/I 123,053 7,200,070 2.25     -
   Poukalov Konstantin Director   –       •       •   2021-02-08 4 B $11.38 $1,503,061 I/I 123,053 14,770,234 2.25     -
  37 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us